Development of national system performance metrics for tissue donation, production, and distribution activity

Abstract

Canada's federal, provincial, and territorial governments gave Canadian Blood Services a mandate for organ and tissue donation and transplantation, including system performance, data and analytics. In 2012 Canadian Blood Services facilitated an eye and tissue banking workshop focused on standardized specifications and practices. At the workshop, the Canadian tissue community directed Canadian Blood Services to facilitate the development and implementation of a national data stream and analytics. Prior to this no national data was prospectively collected or collated on tissue donation, production or distribution activity. An eye and tissue data committee was formed with representation from eye and tissue banks in all Canadian jurisdictions. A minimum data set, standardized definitions, a data submission form and a quality assurance process was developed. Training was provided to data personal identified by each eye and tissue bank. Data collection was initiated January 1, 2013; with quarterly data submitted to Canadian Blood Services via excel spreadsheet. Data was submitted by sixteen Canadian eye and tissue banks, located in eight of Canada's thirteen provinces and territories, representing a census of activity. Annual data reports, with trend analysis, are generated and distributed to the tissue community to inform operational strategy and system performance improvement. This report provides an overview of the data process and provides visibility to the Canadian tissue donation, production and distribution activities for 3 years; January 1, 2013 to December 31, 2015.

Tissue and Cell Donation: Recommendations From an International Consensus Forum

“…Governments and health authorities should develop mechanisms for collecting data on imported and exported tissues to permit the tracking of tissue types, volumes, and locations to help understand the level of dependency on imported tissues and progress on self-sufficiency. 15 …”

“…13,14 Governments and health authorities should develop mechanisms for collecting data on imported and exported tissues to permit the tracking of tissue types, volumes, and locations to help understand the level of dependency on imported tissues and progress on self-sufficiency. 15 A harmonized and common dataset to record the activity data needed by the many relevant stakeholders in the field for different objectives (transparency, biovigilance, service planning, accurate comparisons between jurisdictions participating in import/export exchanges, research, etc) would facilitate benchmarking and minimize the burden on reporting bodies, such as tissue banks, collection centers, and clinical sites. Recent efforts in Europe have led to an agreement on a minimum dataset to meet these goals.…”

Routine procedures and preventive measures in tissue banking and cell therapy during COVID-19 pandemic

“…The main goal for QM in the field of tissue banking and cell therapy is to reduce the risk of disease transmission to tissue recipients. 14…”

COVID-19 and risk management in a tissue bank

“…To evaluate the methodologies of the various processes performed in a TB, Quality Management Systems (QMSs) are set up to address aspects such as personnel training, quality control, corrective actions, guaranteed traceability, and accurate documentation, among others. The fundamental objective of the QMS is to reduce the risk of disease transmission to tissue recipients (2).…”